Pre-hospital ECG in Acute Coronary Syndromes

NCT03699137 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 420048

Last updated 2020-04-06

No results posted yet for this study

Summary

The Pre-Hospital 12-lead electrocardiogram (PHECG) is a simple test that helps ambulance clinicians assess patients with suspected acute coronary syndrome (heart attack), and provides clinical data to inform ongoing care. This project builds on previous work by this team, which found that one in three eligible patients did not receive a PHECG, but those that did had a lowered risk of short-term death. In this study the investigators will update that work, and explore reasons for variations in practice - highlighting opportunities to improve care and outcomes.

Using routinely collected data and qualitative methods, the investigators will research patient, practitioner and contextual factors contributing to the decision to administer a PHECG. The aim is also to develop an intervention to increase the proportion of eligible patients that receive a PHECG, and to produce a proposal for further funding to test this intervention in a subsequent randomised trial.

Conditions

  • Acute Coronary Syndrome
  • STEMI
  • Non STEMI

Interventions

OTHER

No interventions

No interventions

Sponsors & Collaborators

  • Swansea University

    collaborator OTHER
  • University of Leeds

    collaborator OTHER
  • London Ambulance Service

    collaborator OTHER
  • West Midlands Ambulance Service NHS Foundation Trust

    collaborator UNKNOWN
  • South West Ambulance Service NHS Foundation Trust

    collaborator UNKNOWN
  • Kingston University

    lead OTHER

Principal Investigators

  • Tom Quinn, FESC FAHA FACC · Kingston University & St George's, University of London

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-06
Primary Completion
2019-12-31
Completion
2020-04-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03699137 on ClinicalTrials.gov